ZyVersa Therapeutics ZVSA
OTC ZVSA
$0.05 +0.00 (+0.00%)
At close: Oct 19, 2026 · 4:00 PM EDT

ZyVersa Therapeutics, Inc. (ZVSA) Net Cash Flow (2022 - 2026)

Updated

ZyVersa Therapeutics (ZVSA) posted Net Cash Flow of $200,000 for Q1 2026, up 148.1% from $80,608 a year earlier.

Analysis

ZyVersa Therapeutics, Inc. (ZVSA) Net Cash Flow (2022 - 2026) Analysis & Trends

For the trailing twelve months through Mar 31, 2026, Net Cash Flow at ZyVersa Therapeutics was -$1.31 million; for FY2025, it came in at -$1.43 million.

  • In prior years, ZyVersa Therapeutics' Net Cash Flow was -$1.61 million in FY2024, -$2.76 million in FY2023 and $370,743 in FY2022.
  • Quarterly Net Cash Flow has run from a low of -$4.62 million in Q1 2023 to a high of $1.56 million in Q4 2023 over five years.
  • According to Business Quant data, Net Cash Flow for the three prior quarters was -$426,200 (Q4 2025), $462,112 (Q3 2025) and -$1.55 million (Q2 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 200,000.00
Dec 31, 2025 -426,200.00
Sep 30, 2025 462,112.00
Jun 30, 2025 -1.55 Mn
Mar 31, 2025 80,608.00
Dec 31, 2024 1.41 Mn
Sep 30, 2024 3,435.00
Jun 30, 2024 -1.91 Mn
Mar 31, 2024 -1.10 Mn
Dec 31, 2023 1.56 Mn
Sep 30, 2023 1.35 Mn
Jun 30, 2023 -1.05 Mn
Mar 31, 2023 -4.62 Mn
Jun 30, 2022 -490,185.00
Mar 31, 2022 -98,165.00
API Access

ZyVersa Therapeutics, Inc. Net Cash Flow API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-cash-flow&ticker=ZVSA&period=max&api_key=YOUR_API_KEY